The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Oxidative Stress and Vascular Disease
Abstract
Growing evidence indicates that chronic and acute overproduction of reactive oxygen species (ROS) under pathophysiologic conditions is integral in the development of cardiovascular diseases (CVD). These ROS can be released from nicotinamide adenine dinucleotide (phosphate) oxidase, xanthine oxidase, lipoxygenase, mitochondria, or the uncoupling of nitric oxide synthase in vascular cells. ROS mediate various signaling pathways that underlie vascular inflammation in atherogenesis: from the initiation of fatty streak development through lesion progress to ultimate plaque rupture. Various animal models of oxidative stress support the notion that ROS have a causal role in atherosclerosis and other cardiovascular diseases. Human investigations also support the oxidative stress hypothesis of atherosclerosis. Oxidative stress is the unifying mechanism for many CVD risk factors, which additionally supports its central role in CVD. Despite the demonstrated role of antioxidants in cellular and animal studies, the ineffectiveness of antioxidants in reducing cardiovascular death and morbidity in clinical trials has led many investigators to question the importance of oxidative stress in human atherosclerosis. Others have argued that the prime factor for the mixed outcomes from using antioxidants to prevent CVD may be the lack of specific and sensitive biomarkers by which to assess the oxidative stress phenotypes underlying CVD. A better understanding of the complexity of cellular redox reactions, development of a new class of antioxidants targeted to specific subcellular locales, and the phenotype-genotype linkage analysis for oxidative stress will likely be avenues for future research in this area as we move toward the broader use of pharmacological and regenerative therapies in the treatment and prevention of CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, studies show peroxynitrite can traverse cell membranes by both diffusion and through ion channels, suggesting that peroxynitrite can mediate oxidation/nitration distant from its site of formation (221, 611).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [611]
In the citing paper
“Additionally, studies show peroxynitrite can traverse cell membranes by both diffusion and through ion channels, suggesting that peroxynitrite can mediate oxidation/nitration distant from its site of formation (221, 611).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [611]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Role of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,791
Fridovich (1978) · doi:10.1126/science.210504 · Cited by 3,329
Mitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Requirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal Transduction
Sundaresan, M., Yu, Z.-X., Ferrans, V. J., Irani, K., & Finkel, T. (1995) · Science · doi:10.1126/science.270.5234.296 · Cited by 2,520
Research works printed but not linked: 33
- 10.1093/ije/18.3_Supplement_1.S20 · DOI
- 10.1161/atvb.16.7.831 · DOI
- 10.1161/res.80.6.810 · DOI
- 1996, Am J Physiol, 271, H1626
- 10.1161/res.86.5.494 · DOI
- 10.1161/circ.99.15.2027 · DOI
- 10.1161/atvb.21.5.739 · DOI
- 10.1161/atvb.22.1.21 · DOI
- 10.1161/circ.101.12.1372 · DOI
- 10.1161/circ.103.10.1446 · DOI
- 10.1161/circ.103.9.1282 · DOI
- 10.1161/res.86.9.960 · DOI
- 10.1161/hyp.38.6.1395 · DOI
- 10.1161/circ.105.3.393 · DOI
- 10.1161/hyp.37.6.1450 · DOI
- 10.1161/res.89.5.408 · DOI
- 10.1161/hyp.37.2.334 · DOI
- 10.1161/circ.101.14.1653 · DOI
- 10.1161/circ.98.8.794 · DOI
- 10.1161/hyp.32.3.488 · DOI
- 10.1161/res.85.5.437 · DOI
- 10.1161/res.85.4.357 · DOI
- 1994, Am J Physiol, 267, H1804
- 10.1161/res.87.3.241 · DOI
- 10.1161/str.31.8.1889 · DOI
- 10.1161/circ.99.2.224 · DOI
- 10.1161/circ.103.12.1618 · DOI
- 10.1161/res.88.2.e14 · DOI
- 10.1161/circ.101.11.1261 · DOI
- 10.1161/atvb.21.9.1451 · DOI
- 10.1161/circ.88.4.8403327 · DOI
- 10.1161/circ.105.7.849 · DOI
- 10.1161/res.87.12.1074 · DOI
Cited by
Sorted by citations
Items 401–500 of 1,000
Cheung, Y., Karmin, O., Woo, C. W., Armstrong, S., Siow, Y. L., Chow, P., & Cheung, E. W. Y. (2008) · BMC Pediatrics · doi:10.1186/1471-2431-8-20 · Cited by 54
“Oxidized low-density lipoprotein is pro-inflammatory [14,15], causes inhibition of endothelial nitric oxide synthase [16], promotes retention of macrophages in the arterial wall [17], and stimulates vascular smooth muscle cells proliferation [15].”
BackgroundWilson, S. J., Cavanagh, C. C., Lesher, A. M., Frey, A. J., Russell, S. E., & Smyth, E. M. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800447-jlr200 · Cited by 54
“Indeed, similar to other vasoactive mediators (15), NADPH oxidase-derived cellular ROS may be integral to TxA2ʼs cardiovascular actions (16, 17).”
BackgroundProtective effect of Naoxintong against cerebral ischemia reperfusion injury in mice
Xue, J., Zhang, X., Zhang, C., Kang, N., Liu, X., Yu, J., Zhang, N., Wang, H., Zhang, L., Chen, R., et al. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.02.022 · Cited by 54
Tseng, W.-L., Chou, S., Chiang, H.-C., Wang, M., Chien, C., Chen, K.-H., Leu, H., Wang, C., Chang, Y.-L., Liu, Y.-Y., et al. (2017) · Cell Transplantation · doi:10.3727/096368916x694265 · Cited by 54
Song, G., Zong, C., Zhang, Z., Yu, Y., Yao, S., Jiao, P., Tian, H., Zhai, L., Zhao, H., Tian, S., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.018 · Cited by 53
“[28] Madamanchi, N.”
BackgroundMakabe, S., Takahashi, Y., Watanabe, H., Murakami, M., Ohba, T., & Ito, H. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.07.059 · Cited by 53
RETRACTED: Dynamic Action of Carotenoids in Cardioprotection and Maintenance of Cardiac Health
Agarwal, M., Parameswari, R. P., Vasanthi, H. R., & Das, D. K. (2012) · Molecules · doi:10.3390/molecules17044755 · Cited by 53
“In addition, an important initiating event for atherosclerosis may well be the transport of oxidized low-density lipoprotein across the endothelium into the artery wall [3–5].”
BackgroundRetractedHong, H., Li, D., Shen, R., Wang, X., & Shi, D. (2014) · Aquatic Toxicology · doi:10.1016/j.aquatox.2014.04.010 · Cited by 55
Kim, M. J., Moon, M. K., Kang, G. H., Lee, K. J., Choi, S. H., Lim, S. K., Oh, B., Park, D. J., Park, K. S., Jang, H. C., et al. (2013) · Cardiovascular Toxicology · doi:10.1007/s12012-013-9235-x · Cited by 55
Dobi, A., Bravo, S. B., Veeren, B., Paradela‐Dobarro, B., Álvarez, E., Meilhac, O., Viranaïcken, W., Baret, P., Devin, A., & Rondeau, P. (2019) · Free Radical Research · doi:10.1080/10715762.2018.1529866 · Cited by 53
“AGEs-associated oxidative stress, appears as a central element in the pathology of atherosclerosis [8].”
BackgroundInactivation of Src Family Tyrosine Kinases by Reactive Oxygen Species in Vivo
Tang, H., Hao, Q., Rutherford, S. A., Low, B., & Zhao, Z. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503498200 · Cited by 53
Nitric Oxide in the Pathogenesis of Cardiac Disease
Raij, L. R. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.06025.x · Cited by 59
Nomoto, H., Miyoshi, H., Furumoto, T., Oba, K., Tsutsui, H., Miyoshi, A., Kondo, T., Tsuchida, K., Atsumi, T., Manda, N., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135854 · Cited by 54
Ouimet, M. A., Faig, J. J., Yu, W., & Uhrich, K. E. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00824 · Cited by 52
Mitochondrial DNA mutations and cardiovascular disease
Bray, A. W., & Ballinger, S. W. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000383 · Cited by 51
Markers of Atherosclerosis: Part 2 – Genetic and Imaging Markers
Tibaut, M., Čaprnda, M., Kubatka, P., Sinkovič, A., Valentová, V., Filipová, S., Gazdíková, K., Gašpar, Ľ., Mozos, I. M., Egom, E. E. A., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.09.006 · Cited by 52
Oxidized phospholipids mediate occludin expression and phosphorylation in vascular endothelial cells
DeMaio, L., Rouhanizadeh, M., Reddy, S. T., Sevanian, A., Hwang, J., & Hsiai, T. K. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00554.2005 · Cited by 52
“Furthermore, oscillatory flow, which occurs at arterial bifurcations, induces the production of superoxide anion (O2 ) by the vascular endothelium and the oxidative modification of native LDL (25, 37).”
BackgroundMill, C., Monk, B. A., Williams, H. J., Simmonds, S. J., Jeremy, J. Y., Johnson, J. L., & George, S. J. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303922 · Cited by 53
“Oxidative stress is a well-characterized inducer of VSMC apoptosis both in vivo and in vitro.(5,6) Apoptotic VSMCs have been identified throughout the atherosclerotic plaque,(7) particularly within the fibrous cap and underlying media.”
BackgroundKim, H., Yun, J., & Kwon, S. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2483163 · Cited by 54
“These processes occur in various tissues [87, 88], including the heart during myocardial infarction [89], the brain during stroke [90], and the kidneys [91].”
BackgroundOxidative stress as a predictor of cardiovascular events in coronary artery disease patients
Vassalle, C., Bianchi, S. E., Bianchi, F., Landi, P., Battaglia, D. B. R., & Carpeggiani, C. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2011-0919 · Cited by 51
Reduced Paraoxonase 1 Activity as a Marker for Severe Coronary Artery Disease
Zhou, C., Cao, J., Shang, L., Tong, C., Hu, H., Wang, H., Fan, D., & Yu, H. (2013) · Disease Markers · doi:10.1155/2013/816189 · Cited by 52
“Although the mechanisms are still not entirely resolved, previous studies have indicated that dyslipidemia, enhanced oxidative stress, and inflammation result in the development of atherosclerosis and its complications, CAD [1, 2].”
BackgroundSun, D., Nizamutdinova, I. T., Kim, Y. M., Cai, X. F., Lee, J. J., Kang, S. S., Kim, Y. S., Kang, K. M., Chai, G.-Y., Chang, K. C., et al. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.05.006 · Cited by 51
“of the oxidation/reduction state of the cell have been implicated in the pathogenesis of various inflammatory diseases and cancer [16, 17 ] .R OS may be ac ommon intracellular messenger for a variety of redox-sensitive transcription pathwaysthatleadtotheexpressionofcelladhesionmolecules in vascular endothelial cells […”
BackgroundResultInfluentialOxidative stress and cardiovascular health: therapeutic potential of polyphenols
Khurana, S., Piché, M., Hollingsworth, A., Venkataraman, K., & Tai, T. C. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0252 · Cited by 51
“For example, angiotensin II (Ang II), thrombin, platelet-derived growth factor, and tumor necrosis factor all act as agonists that increase NAD(P)H oxidase and subsequent superoxide radical levels (Madamanchi et al. 2005).”
BackgroundInfluentialJacobin‐Valat, M., Laroche‐Traineau, J., Larivière, M., Mornet, S., Sanchez, S., Biran, M., Lebaron, C., Boudon, J., Lacomme, S., Cérutti, M., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.12.006 · Cited by 50
The role of NLRP3 inflammasome in stroke and central poststroke pain
Li, S., Zhang, Y., Ma, S., Yi, Y., Yu, H., Pei, L., & Feng, D. (2018) · Medicine · doi:10.1097/md.0000000000011861 · Cited by 50
Oxidative and Nitrosative Modifications of Tropoelastin Prevent Elastic Fiber Assembly in Vitro
Akhtar, K., Broekelmann, T. J., Miao, M., Keeley, F. W., STARCHER, B. C., Pierce, R. A., Mecham, R. P., & Adair-Kirk, T. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.126789 · Cited by 50
Chung, T. D., Linville, R. M., Guo, Z., Ye, R., Jha, R., Grifno, G. N., & Searson, P. C. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00327-x · Cited by 51
Lockyer, S., Yaqoob, P., Spencer, J. P. E., & Rowland, I. R. (2012) · Nutrition and Aging · doi:10.3233/nua-2012-0011 · Cited by 49
Du, Y., Zhang, W., Zhang, Q., Deng, W., Li, Y., Xing, G., & Shi, X. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.139461 · Cited by 49
“The brain is particularly vulnerable to oxidative stress injury because of its high consumption of oxygen, abundant polyunsaturated fatty acids, and low levels of endogenous antioxidants (Madamanchi et al., 2005; Schreibelt et al., 2007).”
BackgroundLi, W., Maloney, R. E., Circu, M. L., Alexander, J. S., & Aw, T. Y. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.552 · Cited by 49
“It is well appreciated that reactive oxygen species (ROS)1 are major contributors to attenuated endothelial-dependent vascular function in a variety of vascular pathologies [1].”
BackgroundHiggins, P., Dawson, J., & Walters, J. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/282059 · Cited by 49
“The molecular effects and importance of ROS in cardiovascular disease has already been extensively reviewed [52–55].”
BackgroundKeshavarz, P., Gh, B. F. N. M., Mirhafez, S. R., Nematy, M., Azimi–Nezhad, M., Afin, S. A., Esmaily, H., Pourali, L., Mehdizadeh, A., Soukhtanloo, M., et al. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.03.022 · Cited by 49
Fortuño, A., Bidegain, J., Baltanás, A., Moreno, M. U., Montero, L., Landecho, M. F., Beloqui, Ó., Dı́ez, J., & Zalba, G. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833c21af · Cited by 49
Oxidative stress, oxidative balance score, and hypertension among a racially diverse population
Annor, F. B., Goodman, M. G., Okosun, I. S., Wilmot, D., Il’yasova, D., Ndirangu, M., & Lakkur, S. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.05.014 · Cited by 49
“The F2-isoP was extracted from the plasma sample with deuterium (4)-labeled 8-iso-prostaglandin F2 alpha as an internal standard.”
Afzaal, A., Rehman, K., Kamal, S., & Akash, M. S. H. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23047 · Cited by 49
Arterial dissections: Common features and new perspectives
Bax, M., Romanov, V., Junday, K., Giannoulatou, E., Martinac, B., Kovacic, J. C., Liu, R., Iismaa, S. E., & Graham, R. M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1055862 · Cited by 51
“Molecular triggers such as PDGF-BB, TGF-β, actin A, retinoids, angiotensin II, TNF-α, IGF-I, -II, endothelin-1, and NO as well as reactive oxygen species and a reduced glutathione (GSH) redox status, can all modulate the activation state of VSMCs (46, 48, 49).”
BackgroundOhira, M., Endo, K., Oyama, T., Yamaguchi, T., Ban, N., Kawana, H., Nagayama, D., Nagumo, A., Saiki, A., Murano, T., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2010.06.001 · Cited by 47
Si, Y., Zhang, Y., Zhao, J., Guo, S., Zhai, L., Yao, S., Sang, H., Yang, N., Song, G., Gu, J., et al. (2014) · Mediators of Inflammation · doi:10.1155/2014/263786 · Cited by 48
“Increased ROS production can initiate a cascade of signal transduction, which results in endothelial dysfunction, changes in vascular tone, vascular remodeling, and vascular inflammatory responses [25].”
BackgroundMetabolomics and ischaemic heart disease
Rasmiena, A. A., Ng, T. W., & Meikle, P. J. (2012) · Clinical Science · doi:10.1042/cs20120268 · Cited by 48
Chen, X., Zhang, H., McAfee, S., & Zhang, C. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01096.2009 · Cited by 48
Masud, R., Shameer, K., Dhar, A., Ding, K., & Kullo, I. J. (2012) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-2-6 · Cited by 49
“Oxidative-stress response is known to be associated with PAD [53-56]; we noted that several “oxidative-stress response” related functions were enriched in GO term analysis and IPA analysis.”
BackgroundEffects of the Olive Tree Leaf Constituents on Myocardial Oxidative Damage and Atherosclerosis
Efentakis, P., Iliodromitis, E. K., Mikros, E., Papachristodoulou, A., Dagres, N., Skaltsounis, A., & Andreadou, I. (2015) · Planta Medica · doi:10.1055/s-0035-1546017 · Cited by 48
Ardalani, H., Moghadam, M. H., Rahimi, R., Soltani, J., Mozayanimonfared, A., Moradi, M., & Azizi, A. (2016) · RSC Advances · doi:10.1039/c5ra22840a · Cited by 48
Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases
Liu, Y., Shields, L., Gao, Z.-W., Wang, Y.-Y., Zhang, Y.-P., Chu, T., Zhu, Q., Shields, C., & Cai, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0062-5 · Cited by 41
Li, H., Yan, J., Meng, D., Cai, R., Gao, X., Ji, Y., Wang, L., Chen, C., & Wu, X. (2020) · ACS Nano · doi:10.1021/acsnano.0c03629 · Cited by 48
Signal Switching, Crosstalk, and Arrestin Scaffolds
Smith, N. J., & Luttrell, L. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000232641.84521.92 · Cited by 48
Lee, J.-H., & Kim, S. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.07.011 · Cited by 47
“…primary causes of major human diseases such as cancer, neurodegenerative diseases or vascular dysfunction (Reuter et al., 2010; Barnham et al., 2004; Simonian and Coyle, 1996;Madamanchi et al., 2005), which results from the excessive amount of free radicals including reactive oxygen species (ROS).”
BackgroundUnverdorben, M., von Holt, K., & Winkelmann, B. R. (2009) · Biomarkers in Medicine · doi:10.2217/bmm.09.51 · Cited by 48
Elevated level of methylglyoxal during diabetic ketoacidosis and its recovery phase
Turk, Z., Nemet, I., Varga‐Defterdarovič, L., & Car, N. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70266-5 · Cited by 47
Aksoy, Ş., Çam, N., Gürkan, U., Öz, D., Özden, K., Altay, S., Durmuş, G., & Ağırbaşlı, M. A. (2012) · Cardiology Journal · doi:10.5603/cj.2012.0069 · Cited by 47
“Standard CAD risk factors such as smoking, low HDLC, and diabetes mellitus can all alter oxidative indices [22].”
BackgroundXu, J., Yang, W. Q., Deng, Q., Huang, Q., Yang, J., & Huang, F. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-148 · Cited by 49
“Growing evidence indicates that oxidative stress is the pivotal pathogenetic factor and unifying mechanism for atherosclerosis and other cardiovascular diseases [29].”
BackgroundAntioxidants and Cardiovascular Risk Factors
Pellegrino, D. (2016) · Diseases · doi:10.3390/diseases4010011 · Cited by 47
“Furthermore, it has been shown that lower total antioxidant response and higher total peroxide levels are associated with cardiomyopathy, atherosclerosis and coronary artery disease [16–20].”
BackgroundSung, T.-J., Wang, Y., Liu, K.-L., Chou, C.-H., Lai, P., & Hsieh, C.-W. (2020) · Antioxidants · doi:10.3390/antiox9010065 · Cited by 47
Relationship among IL-6, LDL cholesterol and lipid peroxidation
Lubrano, V., Gabriele, M., Puntoni, M. R., Longo, V. G., & Pucci, L. (2015) · Cellular & Molecular Biology Letters · doi:10.1515/cmble-2015-0020 · Cited by 47
Humanin, a Cytoprotective Peptide, Is Expressed in Carotid Artherosclerotic Plaques in Humans
Zacharias, D. G., Kim, S. G., Eirin, A., Bachar, A. R., Oh, Y. K., Herrmann, J., Rodriguez-Porcel, M. G., Cohen, P., Lerman, L. O., & Lerman, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031065 · Cited by 48
“Ox-LDL then propagates the formation of ROS leading to oxidative stress, inflammation, and the formation of atherosclerotic plaque [57,58,59].”
BackgroundGarcía‐Calderó, H., Rodrı́guez-Vilarrupla, A., Gracia‐Sancho, J., Diví, M., Laviña, B., Bosch, J., & García‐Pagán, J. C. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.034 · Cited by 47
“In addition, scavenging of NO by increased levels of superoxide (O2 ) is another factor that has been shown to reduce NO bioavailability [7,8].”
BackgroundDisturbed Flow Induces Autophagy, but Impairs Autophagic Flux to Perturb Mitochondrial Homeostasis
Li, R., Jen, N., Wu, L., Lee, J., Fang, K., Quigley, K., Lee, K. J., Wang, S., Zhou, B., Vergnes, L., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5896 · Cited by 46
“Previous studies demonstrated that OSS induces endothelial O2 - production via activation of the NADPH oxidase enzyme system and c-Jun NH2-terminal kinase ( JNK-1 and JNK-2) signaling (36, 37, 56, 73, 74).”
Lin, J. B., Phillips, E. H., Riggins, T. E., Sangha, G. S., Chakraborty, S., Lee, J. C. L., Lycke, R., Hernandez, C., Soepriatna, A. H., Thorne, B. R. H., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511131 · Cited by 46
“progression could be attributed to initiating factors for atherosclerosis [16], genetic variations [17], demographic, smoking status, inflammatory state, and serum lipoprotein levels [18].”
BackgroundCotti, E., Zedda, A. M., Deidda, M., Piras, A., Flore, G., Ideo, F., Madeddu, C., Pau, V., & Mercuro, G. G. (2015) · Journal of Endodontics · doi:10.1016/j.joen.2015.01.037 · Cited by 46
“JOE — Volume 41, Number 5, May 2015 hypertension, hypercholesterolemia, diabetes, and cigarette smoking, alter many functions of the endothelium (36) and mediate various inflammatory signaling pathways in atherogenesis (37).”
BackgroundReconvene and Reconnect the Antioxidant Hypothesis in Human Health and Disease
Singh, P. P., Chandra, A., Mahdi, F., Roy, A., & Sharma, P. (2010) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-010-0078-y · Cited by 48
Cerebral vascular dysfunction in TallyHo mice: a new model of Type II diabetes
Didion, S. P., Lynch, C. M., & Faraci, F. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00939.2006 · Cited by 46
“Increases in superoxide are associated with endothelial dysfunction in many diseases, including atherosclerosis, hypertension, and Type I diabetes (2, 6, 8, 9, 30).”
BackgroundCheng, Y., Lin, F., Wang, C., Hsiao, C.-Y., Chen, H.-C., Kuo, H.-Y., Tsai, T., & Chiou, S. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.060 · Cited by 47
“Recent studies have found a strong correlation between oxidative stress and CVD, such as hypertension, heart failure and stroke [14-16].”
BackgroundInfluentialTsai, K., Hung, C., Chan, S., Shih, J., Cheng, Y., Tsai, Y., Lin, H.-C., & Chu, P. (2016) · Oncotarget · doi:10.18632/oncotarget.12788 · Cited by 46
Ranganna, K., Mathew, O. P., Yatsu, F. M., Yousefipour, Z., Hayes, B. E., & Milton, S. G. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06119.x · Cited by 46
Efonidipine Reduces Proteinuria and Plasma Aldosterone in Patients with Chronic Glomerulonephritis
Ishimitsu, T., Kameda, T., Akashiba, A., Takahashi, T., Ohta, S., Yoshii, M., Minami, J., Ono, H., Numabe, A., & Matsuoka, H. (2007) · Hypertension Research · doi:10.1291/hypres.30.621 · Cited by 46
Oxidative regulation of the Na+–K+ pump in the cardiovascular system
Figtree, G. A., Karimi, G. K., Liu, C., & Rasmussen, H. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.539 · Cited by 45
Hepel, M., Stobiecka, M., Peachey, J., & Miller, J. E. (2012) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2012.05.005 · Cited by 47
Ushida, Y., Matsui, T., Tanaka, M., Matsumoto, K., Hosoyama, H., Mitomi, A., Sagesaka, Y. M., & Kakuda, T. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.09.005 · Cited by 45
“signaling pathways such as suppression of NO production by NAD(P)H oxidase/ERK1/2 cascade or IP3/PKC cascade, along with Ca channel stimulation [22].”
BackgroundAntioxidants in the Prevention and Treatment of Diabetic Retinopathy – A Review
Baptista-Silva, S., da Costa, J. P. O., Pintado, M., Ferreira, D. D. C., & Sarmento, B. F. C. C. (2010) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000111 · Cited by 48
Sweazea, K. L., Lekic, M., & Walker, B. R. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-48 · Cited by 45
“Background Reactive oxygen species (ROS) have been implicated in the pathogenesis of many diseases including diabetes [1], cardiovascular disease, and ischemia reperfusion injury [2-5].”
BackgroundSilva, M. S. D., Julien, P., Bilodeau, J., Barbier, O., & Rudkowska, I. (2017) · Lipids · doi:10.1007/s11745-017-4243-4 · Cited by 45
Polidori, M. C., Praticò, D., Parente, B., Mariani, E., Cecchetti, R., Yao, Y., Sies, H., Cao, P., Mecocci, P., & Stahl, W. (2007) · Journal of Investigative Medicine · doi:10.2310/6650.2007.06043 · Cited by 45
Lee, S. J., Kim, C. E., Yun, M. R., Seo, K. W., Park, H. M., Yun, J. W., Shin, H. K., Bae, S. S., & Kim, C. D. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.10.007 · Cited by 45
“Atherosclerotic lesion formation is the result of complex interaction between inflammatory and oxidative mechanisms, including lipid peroxidation (Madamanchi et al., 2005; Bonomini et al., 2008; Gamkrelidze et al., 2008).”
BackgroundZhu, H., Cao, Z., Zhang, L., Trush, M. A., & Li, Y. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9396-z · Cited by 45
“In this context, ROS-elicited cytotoxicity to vascular smooth muscle cells, a major type of cells in atherosclerotic lesions, has been implicated in the instability of atherosclerotic plaques and the subsequent thrombosis [25, 26].”
BackgroundFaraci, F. M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000238355.56172.b3 · Cited by 45
Ma, S., Yin, H., Chen, L., Liu, H., Zhao, M., & Zhang, X. (2011) · Journal of Natural Medicines · doi:10.1007/s11418-011-0545-7 · Cited by 44
“saturated fatty acids and low levels of endogenous antioxidants [2, 7, 8].”
BackgroundRisk of peripheral artery disease according to a healthy lifestyle score: The PREDIMED study
López-Laguna, N., Martínez‐González, M. Á., Toledo, E., Babió, N., Sorlí, J. V., Ros, E., Muñoz, M. Á., Estruch, R., Lapetra, J., Muñoz-Bravo, C., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.05.049 · Cited by 44
Noncoding RNAs as Molecular Targets of Resveratrol Underlying Its Anticancer Effects
Wang, M., Jiang, S., Yu, F., Zhou, L., & Wang, K. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01667 · Cited by 44
Carmona-Hernández, J. C., Le, M., Idárraga-Mejía, A. M., & González-Correa, C. H. (2021) · Molecules · doi:10.3390/molecules26216431 · Cited by 54
“Oxidative stress is defined as an imbalance between oxidants and antioxidants in favour of the oxidants, leading to a disruption of redox signalling and control and/or molecular damage [10].”
BackgroundHarrison, C. B., Drummond, G. R., Sobey, C. G., & Selemidis, S. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05317.x · Cited by 44
“Oxidative stress, an overproduction of reactive oxygen species (ROS), is a key risk factor associated with cardiovascular disease and is a distinctive characteristic of both human cases and animal models of atherosclerosis.(17,18) There are many vascular sources of ROS; how-”
BackgroundCould a vegetarian diet reduce exercise-induced oxidative stress? A review of the literature
Trapp, D., Knez, W. L., & Sinclair, W. H. (2010) · Journal of Sports Sciences · doi:10.1080/02640414.2010.507676 · Cited by 44
“The increased presence of free radicals and reactive oxygen species evident during oxidative stress has a pivotal role in lipid peroxidation, which is associated with the development of atherosclerosis (Madamanchi, Vendrov, & Runge, 2005 ; Sen, 1995 ).”
BackgroundRecent perspectives on the medicinal potential of ginger
Rupasinghe, V., & Gunathilake, K. D. P. P. (2015) · Botanics Targets and Therapy · doi:10.2147/btat.s68099 · Cited by 43
“Oxidation of LDL-C has been suggested to play a significant role in the process of development of atherosclerosis.(28) It has been suggested that among all in vitro antioxidant capacity assays, measuring LDL-C antioxidant activity is more pathophysiologically important and more informative for screening antioxidant ac…”
Xu, C., Chen, J., Zhang, J., Hu, X., Zhou, X., Lu, Z., & Jiang, H. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00247 · Cited by 43
Aksakal, E., Tanboğa, İ. H., Kurt, M., Kayğın, M. A., Kaya, A., Işık, T., Ekinci, M., Sevimli, S., & Açıkel, M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.01.044 · Cited by 43
El‐Maghrabey, M., Kishikawa, N., Ohyama, K., & Kuroda, N. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.07.002 · Cited by 43
“Oxidative stress has been implicated in a range of diseased conditions, including diabetes [1], hypertension [2], atherosclerosis [3], Alzheimer's disease”
BackgroundPieme, C. A., Ngoupayo, J., Nkoulou, C., Moukette, B. M., Nono, B. L. N., Moor, V., Minkandé, J. Z., & Ngogang, J. Y. (2014) · Antioxidants · doi:10.3390/antiox3030618 · Cited by 43
“correlated with oxidative stress defense and different human diseases including cancer, atherosclerosis and the aging process [2,3].”
BackgroundDecreased Paraoxonase-2 Expression in Human Carotids During the Progression of Atherosclerosis
Fortunato, G., Taranto, M. D. D., Bracale, U. M., GUERCIO, L. D., Carbone, F., Mazzaccara, C., Morgante, A., D’Armiento, F. P., D'Armiento, M. R., Porcellini, M., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.154658 · Cited by 43
Feine, I., Pinkas, I., Salomon, Y., & Scherz, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041633 · Cited by 43
Dang-li, R., HeKong, W., JiQin, L., Zhang, M., & WenCheng, Z. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1013-0 · Cited by 43
“PDTC is also known to be a p65 activation inhibitor and has been widely used to inhibit the activation of NF-jB in a variety of cell lines [27–31].”
MethodTocotrienol and Its Role in Chronic Diseases
Chin, K., Pang, K.-L., & Soelaiman, I. N. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41334-1_5 · Cited by 43
African Legumes: Nutritional and Health-Promoting Attributes
Duodu, K. G., & Apea-Bah, F. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100866-9.00009-1 · Cited by 43
Bayse, C. A. (2007) · The Journal of Physical Chemistry A · doi:10.1021/jp072297u · Cited by 43
Zhang, Z., Dickerson, I. M., & Russo, A. F. (2005) · Endocrinology · doi:10.1210/en.2005-0918 · Cited by 42
Age alters cerebrovascular inflammation and effects of estrogen
Sunday, L., Osuna, C. E., Krause, D. N., & DUCKLES, S. P. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01057.2006 · Cited by 43
“Many cardiovascular pathologies involve chronic inflammatory processes (3, 10, 18, 25, 27, 29).”
BackgroundVitamin C prevents zidovudine-induced NAD(P)H oxidase activation and hypertension in the rat
Papparella, I., Ceolotto, G., Berto, L., Cavalli, M., Bova, S., Cargnelli, G., Ruga, E. M., Milanesi, O., Franco, L., & Mazzoni, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.010 · Cited by 43
“responsible of the catalytic activity of the oxidase, while p47 plays a key regulatory role in the oxidase activation following its translocation to the cell membrane, where it associates with gp91 and p22 [21,22].”
BackgroundWittfooth, S., Qin, Q., Lund, J., Tierala, I., Pulkki, K. J., Takalo, H., & Pettersson, K. S. I. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.070607 · Cited by 43
Evaluation of oxidative stress in children with congenital heart defects
Pirinccioglu, A. G., Alyan, Ö., Kızıl, G., Kanğın, M., & Beyazıt, N. (2011) · Pediatrics International · doi:10.1111/j.1442-200x.2011.03478.x · Cited by 42
Jin, B. Y., Sartoretto, J. L., Gladyshev, V. N., & Michel, T. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907409106 · Cited by 42
“ROS modulate both physiological and pathophysiological responses, and increased production of ROS is implicated in cardiovascular disease states (1, 2).”
BackgroundGraft microvascular disease in solid organ transplantation
Jiang, X., Sung, Y. K., Tian, W., Qian, J., Semenza, G. L., & Nicolls, M. R. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1173-y · Cited by 43
“Oxidative stress can result from an imbalance between the generation and elimination of ROS and can lead to EC dysfunction or death [112].”
BackgroundSchmidt, S., Stahl, F., Mutz, K., Scheper, T., Hahn, A., & Schuchardt, J. (2012) · Nutrition and Metabolism · doi:10.1186/1743-7075-9-45 · Cited by 45
“Evidence of an association between dyslipidemia and increased oxidative stress [1,2], as well as between increased oxidative stress and the pathogenesis of CVD, are given by many studies [3-7].”
Background
Metadata
- Authors
- Madamanchi, N. R., Vendrov, A., & Runge, M. S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2005-01
- Volume
- 25
- Issue
- 1
- Pages
- 29-38
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2109698138
- Cited by
- 1,618
- References
- 135
- Citations by year
- 2026: 47 · 2025: 46 · 2024: 42 · 2023: 53 · 2022: 61 · 2021: 62 · 2020: 73 · 2019: 73 · 2018: 57 · 2017: 75 · 2016: 78 · 2015: 105 · 2014: 111 · 2013: 104 · 2012: 95
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- oxidative stress, reactive oxygen species, atherosclerosis, vascular disease, cardiovascular disease, NADPH oxidase, xanthine oxidase, lipoxygenase, nitric oxide synthase uncoupling, vascular inflammation, atherogenesis, antioxidants, redox signaling, biomarkers, cardiovascular risk factors
- MeSH terms
- Animals, Humans, Vascular Diseases, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review